☆ 4.6 Letter

Ruling out preeclampsia in the next 4 weeks using a soluble fms-like tyrosine kinase 1/placental growth factor ratio ≤38: secondary analysis of the Interventional Study on Prediction of Preeclampsia/Eclampsia in Women With Suspected Preeclampsia

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2022)

Journal

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Volume 226, Issue 3, Pages 443-445

Publisher

MOSBY-ELSEVIER

DOI: 10.1016/j.ajog.2021.11.1345

Keywords

-

Categories

Obstetrics & Gynecology

Funding

Division of Medical Sciences at the University of Oxford

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Acoustics

Role of placental, fetal and maternal cardiovascular markers in predicting adverse outcome in women with suspected or confirmed pre-eclampsia

M. Reddy, K. Palmer, D. L. Rolnik, E. M. Wallace, B. W. Mol, F. Da Silva Costa

Summary: This study assessed the performance of placental, fetal, and maternal cardiovascular markers in predicting adverse perinatal and maternal outcomes in women with suspected or confirmed pre-eclampsia. The sFlt-1/PlGF ratio showed good performance in predicting adverse perinatal outcomes but had poor predictive ability for adverse maternal outcomes.

ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2022)

Add to Collection

Article Obstetrics & Gynecology

Circulating maternal placental growth factor responses to low-molecular-weight heparin in pregnant patients at risk of placental dysfunction

Kelsey McLaughlin, Sebastian R. Hobson, Anjana Ravi Chandran, Swati Agrawal, Rory C. Windrim, W. Tony Parks, Adrian W. Bowman, Ulla Sovio, Gordon C. Smith, John C. Kingdom

Summary: The study established a gestational age-specific reference range for placental growth factor levels and showed that low-molecular-weight heparin therapy can increase circulating placental growth factor levels in patients, prolonging pregnancy and reducing adverse pregnancy outcomes.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2022)

Add to Collection

Article Medicine, Research & Experimental

Placental growth fActor Repeat sampling for Reduction of adverse perinatal Outcomes in women with suspecTed pre-eclampsia: study protocol for a randomised controlled trial (PARROT-2)

Alice Hurrell, Jenie Sparkes, Kate Duhig, Paul T. Seed, Jenny Myers, Cheryl Battersby, Katherine Clark, Marcus Green, Rachael M. Hunter, Andrew H. Shennan, Lucy C. Chappell, Louise Webster

Summary: The PARROT-2 trial is a multi-centre randomised controlled trial investigating the impact of repeat PIGF-based testing on women with suspected pre-eclampsia between 22-35 weeks of gestation. The primary objective of the trial is to determine whether repeat PIGF-based testing reduces severe adverse outcomes for both mother and baby. The clinical and cost-effectiveness of repeat PIGF-based testing has not yet been evaluated.

TRIALS (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Associations Between Soluble fms-Like Tyrosine Kinase-1 and Placental Growth Factor and Disease Severity Among Women With Preterm Eclampsia and Preeclampsia

Roxanne Hastie, Lina Bergman, Susan P. Walker, Tu'uhevaha Kaitu'u-Lino, Natalie J. Hannan, Fiona Brownfoot, Sonja Schell, Alesia Harper, Ping Cannon, Catherine A. Cluver, Stephen Tong

Summary: The study shows that there is an association between circulating sFlt-1 and PlGF levels and severe adverse maternal outcomes among women with preeclampsia, with levels becoming more deranged with increasing disease severity. This suggests that further angiogenic imbalance may be a pathogenic disease driver responsible for the life-threatening maternal complications in preeclampsia.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

Add to Collection

Article Physiology

Interferon y neutralization reduces blood pressure, uterine artery resistance index, and placental oxidative stress in placental ischemic rats

Olivia K. Travis, Geilda A. Tardo, Chelsea Giachelli, Shani Siddiq, Henry T. Nguyen, Madison T. Crosby, Tyler D. Johnson, Andrea K. Brown, George W. Booz, Alex N. Smith, Jan Michael Williams, Denise C. Cornelius

Summary: In this study, neutralization of IFNy was found to reduce MAP, UARI, and placental ROS levels in RUPP recipients. However, fetal and placental weights in RUPP rats were not improved following anti-IFNy treatment. These findings suggest that IFNy may play a role in the pathophysiology of PE and could be a potential therapeutic target for improving maternal outcomes in PE.

AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Health Outcomes Associated With Clinician-initiated Delivery for Hypertensive Disorders at 34-38 Weeks' Gestation

David A. Savitz, Valery A. Danilack, Jerson Cochancela, Brenna L. Hughes, Dwight J. Rouse, Roee Gutmann

Summary: This study shows that clinician-initiated delivery for late-stage nonsevere hypertensive disorders in pregnancy may increase the risk of adverse maternal and infant outcomes in weeks 34 and 35. However, early delivery for hypertensive pregnancies after 34 weeks does not significantly harm the patients, and extending the gestation to 37 weeks may be beneficial. Therefore, clinicians should consider the risks and benefits when deciding whether to initiate delivery for patients with late-stage hypertensive disorders in pregnancy.

EPIDEMIOLOGY (2022)

Add to Collection

Article Obstetrics & Gynecology

Atypical preeclampsia with systemic lupus erythematosus and elevated soluble fms-like tyrosine kinase 1/placental growth factor ratio

Kazuya Mimura, Takuji Tomimatsu, Masayuki Endo, Tadashi Kimura

Summary: In early pregnancy, the sFlt-1/PlGF ratio may be used to differentiate between exacerbation of systemic lupus erythematosus and preeclampsia.

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Short-Term Prediction of Preeclampsia in Chinese Women Using the Soluble fms-Like Tyrosine Kinase 1/Placental Growth Factor Ratio: A Sub-Analysis of the PROGNOSIS Asia Study

Jinsong Gao, Xianghua Huang, Wen Di, Xiaojing Dong, Wenli Gou, Hong Shi, Zilian Wang, Angela Dietl, Sonja Grill, Martin Hund

Summary: This study demonstrates that the sFlt-1/PlGF ratio cutoff of 38 has high predictive performance for short-term prediction of preeclampsia in Chinese women, helping to reduce unnecessary hospitalization for low-risk women.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Add to Collection

Article Developmental Biology

Comparison of circulating total sFLT-1 to placental-specific sFLT-1 e15a in women with suspected preeclampsia

S. Rowson, M. Reddy, D. L. De Guingand, A. Langston-Cox, S. A. Marshall, F. da Silva Costa, K. R. Palmer

Summary: This study found that using placental-specific sFLT-1 e15a performs comparably to total sFLT-1 in diagnosing preeclampsia, which is particularly helpful in diagnosing early-onset preeclampsia.

PLACENTA (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Paeoniflorin alleviates endothelial dysfunction caused by overexpression of soluble fms-like tyrosine kinase 1 and soluble endoglin in preeclampsia via VEGFA upregulation

Jin Zhang, Wei Hua, Xinyuan Zhao, Fan Yang, Ting Guo, Jianhua Zhang, Xuerong Zheng, Wanqi Liang

Summary: This study confirmed the protective effects of paeoniflorin against preeclampsia-related endothelial damage by upregulating VEGFA to alleviate the injury caused by overexpression of sFlt-1 and sEng.

BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2021)

Add to Collection

Article Obstetrics & Gynecology

Real-world data on the clinical use of angiogenic factors in pregnancies with placental dysfunction

Anne Dathan-Stumpf, Victoria Czarnowsky, Vicky Hein, Theresa Andraczek, Holger Stepan

Summary: This real-world data analysis found a correlation between the soluble fms-like tyrosine kinase-1 to placental growth factor ratio and the severity of preeclampsia and placental dysfunction, providing a useful tool for stratifying patients' outcomes.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2022)

Add to Collection

Article Acoustics

Comparison of ophthalmic artery Doppler with PlGF and sFlt-1/PlGF ratio at 35-37 weeks' gestation in prediction of imminent pre-eclampsia

K. Lau, A. Wright, M. Sarno, N. A. Kametas, K. H. Nicolaides

Summary: This study compared the predictive performance of serum placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1)/PlGF ratio with the competing-risks model utilizing maternal risk factors, mean arterial pressure (MAP), and ophthalmic artery peak systolic velocity (PSV) ratio for predicting pre-eclampsia (PE) delivery. The results showed that ophthalmic artery Doppler combined with maternal risk factors and blood pressure could potentially replace the measurement of PlGF and sFlt-1/PlGF ratio in predicting imminent PE.

ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2022)

Add to Collection

Article Obstetrics & Gynecology

Implementing placental-growth-factor (PLGF) measurements in suspected pre-eclampsia-Challenges in clinical practice

Maria Wojcik, Faris Karouni, Sucheta Jindal, Habiba Kapaya

Summary: The study evaluated the implementation of PLGF-based testing at United Lincolnshire Trust Hospitals, showing a significant decrease in admission rates post-implementation for low-risk group and increased staff adherence to the sFLT-1/PLGF protocol. The high-risk group demonstrated shorter time from test to delivery, earlier gestational age at delivery, and lower birth weight.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2021)

Add to Collection

Article Obstetrics & Gynecology

Placental growth factor testing at 19-23 weeks of gestation as a guide to subsequent care in pregnancy: A prospective observational study

Laura A. Magee, Argyro Syngelaki, Ranjit Akolekar, Peter von Dadelszen, Kypros H. Nicolaides

Summary: This study aimed to investigate the role of serum placental growth factor (PlGF) at 19-23 weeks of gestation in risk identification. The results showed that clinical risk factor screening had limitations in detecting adverse outcomes, and PlGF testing alone did not reduce false positives. Therefore, alternative strategies are needed to improve risk identification.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Decision Threshold for Kryptor sFlt-1/PlGF Ratio in Women With Suspected Preeclampsia: Retrospective Study in a Routine Clinical Setting

Lise Lotte Torvin Andersen, Annemarie Helt, Lene Sperling, Martin Overgaard

Summary: The study evaluated the predictive performance and decision threshold of Kryptor sFlt-1/PlGF ratio in managing women with symptoms of preeclampsia, showing good predictive value for both early-onset and late-onset preeclampsia. A single threshold of 66 is recommended for clinical use in ruling out and ruling in preeclampsia within 1 week.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

Add to Collection

Article Obstetrics & Gynecology

Monitoring the safety of COVID-19 vaccination in pregnancy in the UK: A national study using the UK Obstetric Surveillance System (UKOSS), UK Teratology Information Service (UKTIS) and Vaccination in Pregnancy (VIP) safety monitoring systems

Jonathan L. Richardson, Sally Stephens, Lucy C. Chappell, Helen Campbell, Gayatri Amirthalingam, Shennae O'Boyle, Antoaneta Bukasa, Marian Knight, Kenneth K. Hodson

Summary: This article discusses a national study on the vaccination of pregnant women with COVID-19 vaccines and presents preliminary data collected up to June 15, 2021. The results show that the Pfizer-BioNTech mRNA vaccine is the most common, with most women being vaccinated in their second or third trimester mainly due to occupational infection risk.

OBSTETRIC MEDICINE (2023)

Add to Collection

Article Obstetrics & Gynecology

Factors associated with infection after operative vaginal birth-a secondary analysis of a randomized controlled trial of prophylactic antibiotics for the prevention of infection following operative vaginal birth

Anna B. C. Humphreys, Louise Linsell, Marian Knight

Summary: This study found that timely prophylactic antibiotics could reduce the risk of infection after operative vaginal birth, regardless of the type of perineal trauma. The use of episiotomy, forceps birth, primiparity, and overweight were associated with an increased risk of infection after operative vaginal birth.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2023)

Add to Collection

Letter Medical Laboratory Technology

Pregnancy-specific reference intervals: should we exclude women based on body mass index?

Samuel Dockree, Brian Shine, Tim James, Manu Vatish

ANNALS OF CLINICAL BIOCHEMISTRY (2023)

Add to Collection

Article Public, Environmental & Occupational Health

Defining vulnerability subgroups among pregnant women using pre-pregnancy information: a latent class analysis

J. M. Molenaar, L. van der Meer, L. C. M. Bertens, E. F. de Vries, A. J. M. Waelput, M. Knight, E. A. P. Steegers, J. C. Kiefte-de Jong, J. N. Struijs

Summary: This study aimed to identify classes of vulnerability among pregnant women in the Netherlands using pre-pregnancy data on social risk and protective factors, and validate these classes against adverse outcomes. The study found that vulnerability in pregnant women was characterized by high risk factors in a specific domain and protective factors in others. Furthermore, multidimensional vulnerability was associated with adverse outcomes such as premature birth and caesarean section.

EUROPEAN JOURNAL OF PUBLIC HEALTH (2023)

Add to Collection

Letter Infectious Diseases

A novel near-patient host-protein score predicts COVID-19 deterioration at presentation to secondary care

Rahul Atul Shah, Alexander J. Mentzer, Tim James, Stuart Cox, Kevin Paddon, Jordan Bowen, James N. Fullerton

JOURNAL OF INFECTION (2023)

Add to Collection

Article Obstetrics & Gynecology

Key messages from the UK and Ireland Confidential Enquiries into Maternal Death and Morbidity 2022

Marian Knight

OBSTETRICIAN & GYNAECOLOGIST (2023)

Add to Collection

Article Anesthesiology

A national cohort study to investigate the association between ethnicity and the provision of care in obstetric anaesthesia in England between 2011 and 2021

J. H. Bamber, R. Goldacre, D. N. Lucas, S. Quasim, M. Knight

Summary: Ethnic inequalities exist in obstetric anaesthetic care in the UK, with black women more likely to receive general anaesthesia during caesarean section births and Asian women less likely to receive neuraxial anaesthesia during vaginal births. Further research is needed to understand the causes of these disparities and to address potential remediable factors such as access to appropriate care.

ANAESTHESIA (2023)

Add to Collection

Article Obstetrics & Gynecology

Postpartum haemorrhage in high-resource settings: Variations in clinical management and future research directions based on a comparative study of national guidelines

P. L. M. de Vries, C. Deneux-Tharaux, D. Baud, K. K. Chen, S. Donati, F. Goffinet, M. Knight, R. D'Souzah, M. Sueters, T. van den Akker

Summary: This study compared guidelines on prevention and management of postpartum haemorrhage (PPH) from eight high-income countries. The results show a lack of strong evidence in many areas, indicating the need for a universal definition of (severe) PPH and consensus on blood loss measurement. Future research should focus on the timing and sequence of interventions and their impact on maternal outcomes. The quality of guidelines varied considerably. Rating: 9/10.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2023)

Add to Collection

Article Obstetrics & Gynecology

Incidence and outcomes of uterine rupture in women with unscarred, preterm or prelabour uteri: data from the international network of obstetric survey systems

A. Vierin, G. Vandenberghe, K. Bloemenkamp, S. Berlage, L. Colmorn, C. Deneux-Tharaux, S. Donati, M. Gissler, M. Knight, J. Langhoff-Roos, P. G. Lindqvist, B. Maier, J. van Roosmalen, J. Zwart, K. Roelens

Summary: This study analyzed atypical cases of uterine rupture, including those occurring in unscarred, preterm or prelabour uteri. The study found that these cases are extremely rare but can result in severe maternal and perinatal outcomes.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2023)

Add to Collection

Article Obstetrics & Gynecology

Risk factors associated with stillbirth and adverse perinatal outcomes in dichorionic twin pregnancies complicated by selective fetal growth restriction: a cohort study

E. Kalafat, B. Liu, I. Barratt, R. Bhate, A. Papageorghiou, A. Khalil

Summary: This study investigated the perinatal outcomes of dichorionic twin pregnancies complicated by selective fetal growth restriction (sFGR). The umbilical artery Z-scores were found to be associated with both intrauterine death and adverse perinatal outcomes.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2023)

Add to Collection

Letter Hematology

Clarity of guidelines concerning the care of pregnant women is lost by the use of de-sexed language

Marian Knight, Cathy Nelson-Piercy

BRITISH JOURNAL OF HAEMATOLOGY (2023)

Add to Collection

Letter Medical Laboratory Technology

Exclusion criteria for reference studies: Context is key

Samuel Dockree, Brian Shine, Tim James, Manu Vatish

ANNALS OF CLINICAL BIOCHEMISTRY (2023)

Add to Collection

Editorial Material Obstetrics & Gynecology

UKMidSS update

Marian Knight

OBSTETRICIAN & GYNAECOLOGIST (2023)

Add to Collection

Article Public, Environmental & Occupational Health

The COVID-19 International Drug Pregnancy Registry (COVID-PR): Protocol Considerations

Diego F. Wyszynski, Aris T. Papageorghiou, Cheryl Renz, Torri D. Metz, Sonia Hernandez-Diaz

Summary: This study aims to assess the relative risk of obstetric, neonatal, and infant outcomes associated with the use of drugs specifically indicated for COVID-19 treatment compared with other drug treatment strategies. The COVID-PR is a noninterventional, postmarketing cohort study designed to evaluate the safety profile of each studied drug and its potential effects on neonatal outcomes.

DRUG SAFETY (2023)

Add to Collection

Article Engineering, Biomedical

Multi-scale feature pyramid fusion network for medical image segmentation

Bing Zhang, Yang Wang, Caifu Ding, Ziqing Deng, Linwei Li, Zesheng Qin, Zhao Ding, Lifeng Bian, Chen Yang

Summary: Medical image segmentation is crucial in diagnostic and clinical research. This article proposes a Multi-Scale Feature Pyramid Fusion Network (MS-Net) that combines Multi-Scale Attention Module (MSAM) and Stacked Feature Pyramid Module (SFPM) to improve the accuracy of segmentation. Experimental results show that the proposed MS-Net achieves better segmentation results on different datasets.

INTERNATIONAL JOURNAL OF COMPUTER ASSISTED RADIOLOGY AND SURGERY (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.